Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

INOVIO's Pan-COVID-19 Vaccine Candidate (INO-4802) Induces Broad Immunity Against Major Viral Variants in Preclinical Studies

prnewswireMay 13, 2021

Tag: INOVIO , INO-4802 , Pan-COVID-19 , variant

PharmaSources Customer Service